Common Stock, par value $0.001 per share
- Symbol
- BGMS
- Exchange
- NASDAQ
- Classification
- COMMON
- Status
- Current
Current Report · Items 8.01 · 8-K
Bio Green Med Solution, Inc.
BGMSNASDAQEQUITYCurrent
Other Events
Item 8.01 Other Events. On October 15, 2026, the Board of Directors of Bio Green Med Solution, Inc. (the “Company”) declared a quarterly cash dividend of $0.15 per share on the Company’s 6% Convertible Exchangeable Preferred Stock (the “Preferred Stock”). The dividend is payable on November 1, 2026, to Preferred Stock stockholders of record as of the close of business on October 26, 2026.
Company context
We are a clinical-stage biopharmaceutical company working to develop innovative cancer medicines based on cell cycle, epigenetics and mitosis biology. We are a pioneer company in the field of cancer cell cycle biology with a vision to improve patient healthcare by translating insights in cancer biology into medicines that can overcome resistance and ultimately increase a patient’s overall survival.
Current securities
Registered securities in this filing
Bio Green Med Solution, Inc. · 8-K · Filed 2026-10-16
Disclosure sections
Item 8.01Item 8.01 - Other Events
Item
8.01 Other Events.
On
October 15, 2026, the Board of Directors of Bio Green Med Solution, Inc. (the “Company”) declared a quarterly cash dividend
of $0.15 per share on the Company’s 6% Convertible Exchangeable Preferred Stock (the “Preferred Stock”). The dividend
is payable on November 1, 2026, to Preferred Stock stockholders of record as of the close of business on October 26, 2026.